TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY
Background. Pertussis is a highly contagious bacterial infection of airborne transmission type that still remains a serious problem in Russia and around the world. The only reliable means of specific prophylaxis of pertussis is vaccination. In Russia, only one revaccination from pertussis is provide...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2017-02-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1487 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695734784327680 |
|---|---|
| author | A. G. Gaivoronskaya L. S. Namazova-Baranova D. A. Novikova M. V. Fedoseenko N. E. Tkachenko T. A. Kaljuzhnaya F. Ch. Shakhtakhtinskaya М. I. Broeva |
| author_facet | A. G. Gaivoronskaya L. S. Namazova-Baranova D. A. Novikova M. V. Fedoseenko N. E. Tkachenko T. A. Kaljuzhnaya F. Ch. Shakhtakhtinskaya М. I. Broeva |
| author_sort | A. G. Gaivoronskaya |
| collection | DOAJ |
| description | Background. Pertussis is a highly contagious bacterial infection of airborne transmission type that still remains a serious problem in Russia and around the world. The only reliable means of specific prophylaxis of pertussis is vaccination. In Russia, only one revaccination from pertussis is provided at the age of one and a half years, which is done with whole-cell DTP vaccine, which is not used with children older than 4 years due to high reactogenicity. Imported acellular DTP vaccines are an alternative to whole-cell vaccines licensed for use with older children. Objective: Our aim was to study children’s tolerability of the vaccine containing acellular pertussis component. Methods. The safety of acellular DTP vaccines (DTaP, DTaP/IPV/Hib) has been analyzed in a retrospective study with children older than 4 years at the department of vaccinal prevention of Scientific Center of Children’s Health (Moscow) in the period from December 2014 to December 2015.Results. The results of 123 vaccinated children aged 4 to 9 have been studies. Among them, healthy children — 62, those having allergic disease — 30, those with other chronic diseases — 31. In the post-vaccination period (3–7 days), local reactions (weak and/or strong) were recorded with 19 (31%) healthy children, 11 (37%) with children having allergic diseases, 9 (29%) with children having other chronic diseases. General reactions to vaccination (weak and/or strong) occurred with 11 (18%), 6 (20%), and 8 (26%) children respectively. Conclusion. The compared groups did not differ in frequency of post-vaccination reactions and their intensity, with the exception of strong local reactions that occurred more frequently with children having allergic diseases. |
| format | Article |
| id | doaj-art-e626c25dbba64a62a3c2cea13b3df520 |
| institution | DOAJ |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2017-02-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-e626c25dbba64a62a3c2cea13b3df5202025-08-20T03:19:41ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892017-02-0113660160610.15690/pf.v13i6.16761464TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDYA. G. Gaivoronskaya0L. S. Namazova-Baranova1D. A. Novikova2M. V. Fedoseenko3N. E. Tkachenko4T. A. Kaljuzhnaya5F. Ch. Shakhtakhtinskaya6М. I. Broeva7Scientific Centre of Children HealthScientific Centre of Children Health; Sechenov First Moscow State Medical University; N.I. Pirogov Russian National Research Medical UniversityScientific Centre of Children HealthScientific Centre of Children Health; Sechenov First Moscow State Medical UniversityScientific Centre of Children HealthScientific Centre of Children HealthScientific Centre of Children HealthScientific Centre of Children Health; Sechenov First Moscow State Medical UniversityBackground. Pertussis is a highly contagious bacterial infection of airborne transmission type that still remains a serious problem in Russia and around the world. The only reliable means of specific prophylaxis of pertussis is vaccination. In Russia, only one revaccination from pertussis is provided at the age of one and a half years, which is done with whole-cell DTP vaccine, which is not used with children older than 4 years due to high reactogenicity. Imported acellular DTP vaccines are an alternative to whole-cell vaccines licensed for use with older children. Objective: Our aim was to study children’s tolerability of the vaccine containing acellular pertussis component. Methods. The safety of acellular DTP vaccines (DTaP, DTaP/IPV/Hib) has been analyzed in a retrospective study with children older than 4 years at the department of vaccinal prevention of Scientific Center of Children’s Health (Moscow) in the period from December 2014 to December 2015.Results. The results of 123 vaccinated children aged 4 to 9 have been studies. Among them, healthy children — 62, those having allergic disease — 30, those with other chronic diseases — 31. In the post-vaccination period (3–7 days), local reactions (weak and/or strong) were recorded with 19 (31%) healthy children, 11 (37%) with children having allergic diseases, 9 (29%) with children having other chronic diseases. General reactions to vaccination (weak and/or strong) occurred with 11 (18%), 6 (20%), and 8 (26%) children respectively. Conclusion. The compared groups did not differ in frequency of post-vaccination reactions and their intensity, with the exception of strong local reactions that occurred more frequently with children having allergic diseases.https://www.pedpharma.ru/jour/article/view/1487pertussisacellular vaccineswhole-cell vaccinesvaccinationbordetellapertussis |
| spellingShingle | A. G. Gaivoronskaya L. S. Namazova-Baranova D. A. Novikova M. V. Fedoseenko N. E. Tkachenko T. A. Kaljuzhnaya F. Ch. Shakhtakhtinskaya М. I. Broeva TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY Педиатрическая фармакология pertussis acellular vaccines whole-cell vaccines vaccination bordetellapertussis |
| title | TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY |
| title_full | TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY |
| title_fullStr | TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY |
| title_full_unstemmed | TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY |
| title_short | TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY |
| title_sort | tolerance of children older than 4 years to acellular dpt vaccines results of a retrospective study |
| topic | pertussis acellular vaccines whole-cell vaccines vaccination bordetellapertussis |
| url | https://www.pedpharma.ru/jour/article/view/1487 |
| work_keys_str_mv | AT aggaivoronskaya toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT lsnamazovabaranova toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT danovikova toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT mvfedoseenko toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT netkachenko toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT takaljuzhnaya toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT fchshakhtakhtinskaya toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy AT mibroeva toleranceofchildrenolderthan4yearstoacellulardptvaccinesresultsofaretrospectivestudy |